No association of a non-synonymous PLAU polymorphism with Alzheimer's disease and disease-related traits

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 132 B, Issue 1, 2005, Pages 21-23

  Papassotiropoulos, Andreas ^a   Tsolaki, Magdalini ^b   Wollmer, M Axel ^a   Molyva, Dimitra ^b   Thal, Dietmar R ^c   Huynh, Kim Dung ^a   Tracy, Jay ^a   Staehelin, Hannes B ^d   Monsch, Andreas U ^d   Nitsch, Roger M ^a   Hock, Christoph ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Chromosome 10; Complex disease; Genetic linkage; Genetics; Quantitative trait

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CEREBROSPINAL FLUID; CHROMOSOME 10; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GREECE; HUMAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM; SWITZERLAND; TEMPORAL LOBE;

AGED; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CASE-CONTROL STUDIES; GENE FREQUENCY; GENOTYPE; GREECE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; SWITZERLAND; URINARY PLASMINOGEN ACTIVATOR;

EID: 19944427202     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30103     Document Type: Article

References (18)

1. Berres M, Monsch AU, Bernasconi F, Thalmann B, Stahelin HB. 2000. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Stud Health Technol Inform 77:195-199.
2. Ertekin Taner N, Ronald J, Tucker M, Younkin S, Younkin L, Hella M, et al. 2002. Significant association of haplotype blocks on chromosome 10 with Abeta42 and late onset Alzheimer's disease. Washington, DC: Society for Neuroscience, Program No. 420.4.
3. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, et al. 2000. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290:2303-2304.
4. Finckh U, Van Hadeln K, Muller-Thomsen T, Alberici A, Binetti G, Hock C, et al. 2003. Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics 4:213-217.
5. Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA, et al. 1997. Heritability for Alzheimer's disease: The study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci 52:M117-M125.
6. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. 1982. A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
7. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, et al. 1999. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8:237-245.
8. Klopp N, Schwarz S, Padovani A, Kölsch H, Bickeböller H, Wagenpfeil S, et al. 2003. A polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Birmingham: European Human Genetic Conference, 801p.
9. Ledesma MD, Da Silva JS, Crassaerts K, Delacourte A, De Strooper B, Dotti CG. 2000. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep 1:530-535.
10. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, et al. 2002. Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 114:235-244.
11. Myers AJ, Marshall H, Holmans P, Compton D, Crook RJP, Mander AP, et al. 2004. Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD. Am J Med Genet 124B(1):29-37.
12. Nauck M, Hoffmann MM, Wieland H, Marz W. 2000. Evaluation of the apoE genotyping kit on the LightCycler. Clin Chem 46:722-724.
13. Tanzi RE, Bertram L. 2001. New frontiers in Alzheimer's disease genetics. Neuron 32:181-184.
14. Thai DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, et al. 2000. Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733-748.
15. Thai DR, Rub U, Orantes M, Braak H. 2002. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800.
16. Tucker HM, Kihiko M, Caldwell JN, Wright S, Kawarabayashi T, Price D, et al. 2000. The plasmin system is induced by and degrades amyloid-beta aggregates. J Neurosci 20:3937-3946.
17. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. 1991. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 48:278-281.
18. Zubenko GS, Hughes HB, Stiffler JS, Hurtt MR, Kaplan BB. 1998. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution. Genomics 50:121-128.